B R Davis

Summary

Affiliation: Texas Medical Center
Country: USA

Publications

  1. ncbi request reprint Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group
    B R Davis
    University of Texas School of Public Health, Houston 77030, USA
    Stroke 29:1333-40. 1998
  2. ncbi request reprint Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management
    B R Davis
    Coordinating Center for Clinical Trials, University of Texas School of Public Health, Houston 77030
    Am J Hypertens 7:926-32. 1994
  3. ncbi request reprint Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group
    B R Davis
    University of Texas School of Public Health, Houston, USA
    Am J Hypertens 9:342-60. 1996
  4. ncbi request reprint Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP)
    J B Kostis
    Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick 08903-0019, USA
    Am J Hypertens 8:1147-53. 1995
  5. ncbi request reprint Antihypertensive therapy, the alpha-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study
    B R Davis
    School of Public Health, University of Texas Houston, Houston, TX 77030, USA
    Pharmacogenomics J 7:112-22. 2007
  6. ncbi request reprint Sex-specific effects of AGT-6 and ACE I/D on pulse pressure after 6 months on antihypertensive treatment: the GenHAT study
    A I Lynch
    University of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis, Minnesota, USA
    Ann Hum Genet 71:735-45. 2007
  7. ncbi request reprint Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project
    J Simes
    University of Sydney, Sydney, Australia
    Eur Heart J 23:207-15. 2002
  8. ncbi request reprint Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study
    D K Arnett
    University of Minnesota, Division of Epidemiology, Minneapolis, 55454 1015, USA
    Pharmacogenomics J 2:309-17. 2002
  9. pmc Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery
    K W Garey
    University of Houston, College of Pharmacy, Texas Medical Center, 1441 Moursund Street, Houston, TX 77030, USA
    Antimicrob Agents Chemother 52:446-51. 2008

Detail Information

Publications9

  1. ncbi request reprint Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group
    B R Davis
    University of Texas School of Public Health, Houston 77030, USA
    Stroke 29:1333-40. 1998
    ..We sought to determine risk factors for stroke and stroke type in persons with isolated systolic hypertension (ISH)...
  2. ncbi request reprint Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management
    B R Davis
    Coordinating Center for Clinical Trials, University of Texas School of Public Health, Houston 77030
    Am J Hypertens 7:926-32. 1994
    ..95 (P = .71). This study provides no support for the sole use of a low-sodium/high-potassium diet as a practical therapeutic strategy in maintaining blood pressure control in the moderately obese...
  3. ncbi request reprint Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group
    B R Davis
    University of Texas School of Public Health, Houston, USA
    Am J Hypertens 9:342-60. 1996
    ..The mean duration of treatment and follow-up is planned to be 6 years. Further features of the rationale, design, objectives, treatment program, and study organization of ALLHAT are described in this article...
  4. ncbi request reprint Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP)
    J B Kostis
    Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, New Brunswick 08903-0019, USA
    Am J Hypertens 8:1147-53. 1995
    ..However, a greater number of patients might have been necessary to adequately evaluate potential differential effects of these drugs, especially for reserpine...
  5. ncbi request reprint Antihypertensive therapy, the alpha-adducin polymorphism, and cardiovascular disease in high-risk hypertensive persons: the Genetics of Hypertension-Associated Treatment Study
    B R Davis
    School of Public Health, University of Texas Houston, Houston, TX 77030, USA
    Pharmacogenomics J 7:112-22. 2007
    ..This must be confirmed to have implications for hypertension treatment...
  6. ncbi request reprint Sex-specific effects of AGT-6 and ACE I/D on pulse pressure after 6 months on antihypertensive treatment: the GenHAT study
    A I Lynch
    University of Minnesota, Department of Laboratory Medicine and Pathology, Minneapolis, Minnesota, USA
    Ann Hum Genet 71:735-45. 2007
    ..For ACE-I/D no evidence for a genotype-by-sex interaction was detected. This finding of genotype-by-sex interaction on PP helps our understanding of the complexity of genetic effects on blood pressure...
  7. ncbi request reprint Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project
    J Simes
    University of Sydney, Sydney, Australia
    Eur Heart J 23:207-15. 2002
    ....
  8. ncbi request reprint Pharmacogenetic approaches to hypertension therapy: design and rationale for the Genetics of Hypertension Associated Treatment (GenHAT) study
    D K Arnett
    University of Minnesota, Division of Epidemiology, Minneapolis, 55454 1015, USA
    Pharmacogenomics J 2:309-17. 2002
    ..To our knowledge, GenHAT is the largest pharmacogenetic study ever conducted. An added strength is its ability to link gene-treatment interactions with important clinical outcomes across diverse ethnic and gender groups...
  9. pmc Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery
    K W Garey
    University of Houston, College of Pharmacy, Texas Medical Center, 1441 Moursund Street, Houston, TX 77030, USA
    Antimicrob Agents Chemother 52:446-51. 2008
    ....